Central nervous system lymphoma: iconographic essay

Abstracts

Ilustramos este ensaio iconográfico de linfoma do sistema nervoso central com imagens de ressonância magnética obtidas em nosso serviço nos últimos 13 anos e discutimos algumas das principais características radiológicas deste tipo de linfoma, primário e secundário. O linfoma sistema nervoso central é um tumor relativamente infrequente, mas alguns achados na ressonância magnética podem sugerir este diagnóstico.

Linfoma; Sistema nervoso central; Ressonância magnética

ICONOGRAPHIC ESSAY ENSAIO ICONOGRÁFICO

Central nervous system lymphoma: iconographic essay^*

Fabiano Reis^I; Ricardo Schwingel^II; Felipe Barjud Pereira do Nascimento^III

^IPhD, Teacher responsible for the Sector of Neuroradiology, Professor at Faculdade de Ciências Médicas da Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brazil

^IIGraduate Student of Medicine (6th year) at Faculdade de Ciências Médicas da Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brazil

^IIIMD, Radiologist, Fellow of Neuroradiology, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil

^{Mailing Address}

ABSTRACT

The authors illustrate the present pictorial essay about central nervous system lymphoma with magnetic resonance images obtained in their institution over the past 13 years. Some of the main radiological findings in primary and secondary presentations of this type of lymphoma are discussed. Central nervous system lymphoma is a relatively uncommon tumor, but magnetic resonance imaging findings may suggest the diagnosis.

Keywords: Lymphoma; Central nervous system; Magnetic resonance imaging.

INTRODUCTION

Central nervous system (CNS) lymphoma may present as a primary disease, however, it is more frequently found as a secondary disease. In a survey carried out in the USA between 2004 and 2008, lymphomas represented 2.3% of CNS primary tumors, most commonly found in men (1.38:1) and after the sixth decade of life⁽¹⁾. Typically, primary CNS lymphoma (PCNSL) is a B-cell non-Hodgkin's lymphoma but occasionally it may manifest as T-cell lymphoma, intravascular lymphomatosis or Hodgkin's lymphoma^(2,3). On the other hand, in cases where the CNS involvement is not primary, CNS metastasis occurs in 2% to 15% of non-Hodgkin's lymphomas. Primary or acquired immunodeficiency is also associated with higher risks for development of primary or secondary CNS lymphoma⁽²⁾.

The early diagnosis of CNS lymphomas depends upon the understanding by radiologists of their varied presentations at magnetic resonance imaging (MRI). The present study reviews images obtained over the past 13 years in the Radiology Service at Hospital das Clínicas – Universidade Es­tadual de Campinas (Unicamp). The diagnoses were duly confirmed by histopathology, and the project was approved by Committee for Ethics in Research of the School of Medical Sciences of Unicamp.

RADIOLOGICAL CHARACTERISTICS

As regards the location of lesions, supratentorial region is generally more frequently affected than the infratentorial region. In cases of deep intra-axial lesions, striatocapsular regions and the corpus callosum are affected with a certain frequency. However, lesions may be observed in other sites such as the hypophysis, cavernous sinus, hypothalamus, pineal gland, and posterior fossa. Periventricular or superficial lesions, in contact with the meningeal or ventricular surfaces (intraventricular lesions for example), are commonly found^(2–7).

In immunocompetent patients, CNS lymphoma tends to present as a single and solid large mass, with tumor cells which tend to be monoclonal. Often, the patient's age at the disease onset is higher and the survival is longer. Such single lesions, with high cellularity and generally without necrosis, present preponderantly hyposignal (or isosignal) on T2-weighted and isosignal on T1-weighted images, and demonstrate intense enhancement after intravenous injection of paramagnetic contrast agent.

The presence of this kind of lesion involving the corpus callosum is highly suggestive of lymphoma (Figure 1)⁽⁵⁾. Additionally, not only the image but also the frequent subependimal dissemination can demonstrate the common perilesional edema which occurs in varied degrees and the mass effect (Figure 2A)^(4–7).

Several significant similarities may be found between patients with acquired immunodeficiency syndrome and patients with other forms of immunosuppression. In such cases, there is a higher probability of PCNSLs presenting as multifocal lesions (Figures 3A and 3B) with necrosis (Figures 4A and 4B) and differentiation between them and toxoplasmosis may be difficult.

In regard to contrast-enhancement, several series have demonstrated that its absence can be considered as being rare in CNS lymphomas (Figure 5)^(5,6).

Pachy- or leptomeningeal involvement is more commonly found in secondary lymphomas or in immunocompromised patients. Additionally, appearance of dural/pachymeningeal lesions may be similar to that of meningiomas (Figures 6 and 7)⁽⁴⁾. Secondary CNS involvement by non Hodgkin's lymphoma generally occurs by leptomeningeal infiltration (found in up to two thirds of cases) and infiltration of peri­vascular spaces resulting in parenchymal lesions (observed in one third of cases – Figures 8 and 9)^(2,3). Lesions affecting cranial nerves are relatively rare and may be solitary or multiple (Figure 10)^(3,4,8). On the other hand, in Hodgkin's lymphoma, primary CNS involvement is rare and secondary involvement represents a late manifestation of disseminated disease (Figure 11).

SPECTROSCOPY

Proton magnetic resonance spectroscopy provides graphs which allow the analysis of specific tumor tissue metabolites, particularly in cases of parenchymal lesions. With this complementary method, it is possible to evaluate the levels of choline (peak ant 3.2 ppm), which marks cell membranes biosynthesis; N-acetylaspartate (NAA) (2.0 ppm), related to neuronal and axonal number and viability; creatine (3.02 and 4.0 ppm), utilized as a reference for its stability and a marker of oxidative phosphorylation of normal brain metabolism; lactate (1.3 ppm), related to anaerobic metabolism observed in anaerobiosis; lipids (usually between 0.9 and 1.3 ppm), related to necrosis⁽⁹⁾. In CNS lymphomas, it is common to observe a pattern of increased choline levels, decreased NAA, increased lipids (moreover in the solid component without necrosis, an information that helps the differential diagnosis with glial lesions, in which such peak is usually observed in the necrotic component) (Figures 2B, 3C, 4C and 9E). It has been suggested that spectroscopy might be useful in differentiation between lymphoma, glioblastoma multiforme and metastases⁽¹⁰⁾. It is important to observe that with echo time of 135-144 ms, lactate is characterized by a double peak inverted below baseline. However this peak can be demonstrated at approximately 1.3 ppm above baseline with short echo time (30 or 35 ms) and with very high echo time (270 or 288 ms) lipids are suppressed and lactate is seen as a double peak above the baseline^(4,5,9).

DIFFUSION

Diffusion-weighted MR images measure the apparent diffusion coefficient (ADC) which is inversely proportional to cell density, presumably resulting from the tortuosity of the interstitial space and consequential limitation of water movement. Although not always observable, CNS lymphoma tends to present a low ADC value at diffusion-weighted MRI because of its high cellularity, characteristically presenting restriction in those lesions without necrosis (Figures 6D, 6E, 9C and 9D)^(2,5,10).

PERFUSION

Perfusion-weighted MRI techniques evaluate the microcirculation allowing the calculation of physical parameters such as cerebral blood volume (CBV), cerebral blood flow, and mean transit time. Typically, lymphomatous lesions present low CBV (Figure 12). The maximum relative CBV measured in the tumor and its relationship with the contralateral parenchyma is low as compared with that of other brain tumors⁽²⁾.

CONCLUSION

CNS lymphomas may present with varied forms, however some findings can contribute to facilitate the differential diagnosis which includes gliomas, metastases, and inflammatory diseases. The finding of an expansile supratentorial solid lesion hypointense on T2-weighted images, with no signs of necrosis, lipids peak in the solid component, low perfusion and diffusion restriction, favors the possibility of such diagnosis.

REFERENCES

1. Central Brain Tumor Registry of the United States. CBTRUS Statistical Report: Primary brain and central nervous system tumors diagnosed in the United States in 2004-2008. Hinsdale, IL: Central Brain Tumor Registry of the United States; 2012.

2. Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol. 2011;32:984–92.

3. Slone HW, Blake JJ, Shah R, et al. CT and MRI findings of intracranial lymphoma. AJR Am J Roentgenol. 2005;184:1679–85.

4. Besada C, Schvartzman P, Paganini L, et al. Neuroimágenes estructurales y funcionales en la caracterización del linfoma del SNC. Rev Argent Radiol. 2010;74:147–53.

5. Küker W, Nägele T, Korfel A, et al. Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol. 2005;72:169–77.

6. Schwingel R, Reis F, Zanardi VA, et al. Central nervous system lymphoma: magnetic resonance imaging features at presentation. Arq Neuro­psiquiatr. 2012;70:97–101.

7. Nacif MS, Jauregui GF, Mello RAF, et al. Linfoma adrenal primário bilateral com envolvimento do sistema nervoso central: relato de caso. Radiol Bras. 2005;38:235–8.

8. Garcia MM, Martins JCT. Avaliação por imagem das lesões isoladas do III par craniano. Radiol Bras. 2005;38:219–23.

9. Horská A, Barker PB. Imaging of brain tumors: MR spectroscopy and metabolic imaging. Neuroimaging Clin N Am. 2010;20:293–310.

10. Chawla S, Zhang Y, Wang S, et al. Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases. J Comput Assist Tomogr. 2010;34:836–41.

Received July 16, 2012.

Accepted after revision November 5, 2012.

*

Study developed at Hospital das Clínicas da Faculdade de Ciências Médicas da Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brazil. Financial support: Fundação de Amparo à Pesquisa do Estado de São Paulo (Fapesp) – Process No. 2010/01939-0.

Publication Dates

• Publication in this collection
  07 May 2013
• Date of issue
  Apr 2013

History

• Received
  16 July 2012
• Accepted
  05 Nov 2012